Literature DB >> 22524152

RS-Predictor models augmented with SMARTCyp reactivities: robust metabolic regioselectivity predictions for nine CYP isozymes.

Jed Zaretzki1, Patrik Rydberg, Charles Bergeron, Kristin P Bennett, Lars Olsen, Curt M Breneman.   

Abstract

RS-Predictor is a tool for creating pathway-independent, isozyme-specific, site of metabolism (SOM) prediction models using any set of known cytochrome P450 (CYP) substrates and metabolites. Until now, the RS-Predictor method was only trained and validated on CYP 3A4 data, but in the present study, we report on the versatility the RS-Predictor modeling paradigm by creating and testing regioselectivity models for substrates of the nine most important CYP isozymes. Through curation of source literature, we have assembled 680 substrates distributed among CYPs 1A2, 2A6, 2B6, 2C19, 2C8, 2C9, 2D6, 2E1, and 3A4, the largest publicly accessible collection of P450 ligands and metabolites released to date. A comprehensive investigation into the importance of different descriptor classes for identifying the regioselectivity mediated by each isozyme is made through the generation of multiple independent RS-Predictor models for each set of isozyme substrates. Two of these models include a density functional theory (DFT) reactivity descriptor derived from SMARTCyp. Optimal combinations of RS-Predictor and SMARTCyp are shown to have stronger performance than either method alone, while also exceeding the accuracy of the commercial regioselectivity prediction methods distributed by Optibrium and Schrödinger, correctly identifying a large proportion of the metabolites in each substrate set within the top two rank-positions: 1A2 (83.0%), 2A6 (85.7%), 2B6 (82.1%), 2C19 (86.2%), 2C8 (83.8%), 2C9 (84.5%), 2D6 (85.9%), 2E1 (82.8%), 3A4 (82.3%), and merged (86.0%). Comprehensive datamining of each substrate set and careful statistical analyses of the predictions made by the different models revealed new insights into molecular features that control metabolic regioselectivity and enable accurate prospective prediction of likely SOMs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524152      PMCID: PMC3449220          DOI: 10.1021/ci300009z

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  63 in total

1.  Development of a combined protein and pharmacophore model for cytochrome P450 2C9.

Authors:  Marcel J de Groot; Alexander A Alex; Barry C Jones
Journal:  J Med Chem       Date:  2002-05-09       Impact factor: 7.446

2.  A model for predicting likely sites of CYP3A4-mediated metabolism on drug-like molecules.

Authors:  Suresh B Singh; Lucy Q Shen; Matthew J Walker; Robert P Sheridan
Journal:  J Med Chem       Date:  2003-04-10       Impact factor: 7.446

3.  EaMEAD: Activation energy prediction of cytochrome P450 mediated metabolism with effective atomic descriptors.

Authors:  Doo Nam Kim; Kwang-Hwi Cho; Won Seok Oh; Chang Joon Lee; Sung Kwang Lee; Jihoon Jung; Kyoung Tai No
Journal:  J Chem Inf Model       Date:  2009-07       Impact factor: 4.956

4.  Ligand-Based Site of Metabolism Prediction for Cytochrome P450 2D6.

Authors:  Patrik Rydberg; Lars Olsen
Journal:  ACS Med Chem Lett       Date:  2011-11-07       Impact factor: 4.345

5.  Catalytic site prediction and virtual screening of cytochrome P450 2D6 substrates by consideration of water and rescoring in automated docking.

Authors:  Chris de Graaf; Chris Oostenbrink; Peter H J Keizers; Tushar van der Wijst; Aldo Jongejan; Nico P E Vermeulen
Journal:  J Med Chem       Date:  2006-04-20       Impact factor: 7.446

6.  Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9.

Authors:  Ismael Zamora; Lovisa Afzelius; Gabriele Cruciani
Journal:  J Med Chem       Date:  2003-06-05       Impact factor: 7.446

7.  Construction and assessment of models of CYP2E1: predictions of metabolism from docking, molecular dynamics, and density functional theoretical calculations.

Authors:  Jin-Young Park; Dan Harris
Journal:  J Med Chem       Date:  2003-04-24       Impact factor: 7.446

Review 8.  Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development.

Authors:  Bo Wang; Shu-Feng Zhou
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis.

Authors:  Francesmary Modugno; Carmela Knoll; Amal Kanbour-Shakir; Marjorie Romkes
Journal:  Breast Cancer Res Treat       Date:  2003-12       Impact factor: 4.872

10.  Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosa.

Authors:  Ina Bergheim; Christiane Bode; Alexandr Parlesak
Journal:  BMC Clin Pharmacol       Date:  2005-10-27
View more
  22 in total

1.  Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6.

Authors:  Mara R Livezey; Erran D Briggs; Amanda K Bolles; Leslie D Nagy; Rina Fujiwara; Laura Lowe Furge
Journal:  Xenobiotica       Date:  2013-09-06       Impact factor: 1.908

2.  Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations.

Authors:  Preeti Pragyan; Siddharth S Kesharwani; Prajwal P Nandekar; Vijay Rathod; Abhay T Sangamwar
Journal:  Mol Divers       Date:  2014-07-16       Impact factor: 2.943

3.  Prediction of UGT-mediated Metabolism Using the Manually Curated MetaQSAR Database.

Authors:  Angelica Mazzolari; Avid M Afzal; Alessandro Pedretti; Bernard Testa; Giulio Vistoli; Andreas Bender
Journal:  ACS Med Chem Lett       Date:  2019-02-12       Impact factor: 4.345

4.  QSAR model based on weighted MCS trees approach for the representation of molecule data sets.

Authors:  Bernardo Palacios-Bejarano; Gonzalo Cerruela García; Irene Luque Ruiz; Miguel Ángel Gómez-Nieto
Journal:  J Comput Aided Mol Des       Date:  2013-02-06       Impact factor: 3.686

5.  Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism.

Authors:  Tyler B Hughes; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2017-02-02       Impact factor: 3.739

6.  Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione.

Authors:  Tyler B Hughes; Grover P Miller; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2015-03-16       Impact factor: 3.739

7.  Mechanism-based inactivation of human cytochrome P450 3A4 by two piperazine-containing compounds.

Authors:  Amanda K Bolles; Rina Fujiwara; Erran D Briggs; Amin A Nomeir; Laura Lowe Furge
Journal:  Drug Metab Dispos       Date:  2014-10-01       Impact factor: 3.922

8.  Computationally Assessing the Bioactivation of Drugs by N-Dealkylation.

Authors:  Na Le Dang; Tyler B Hughes; Grover P Miller; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2018-02-06       Impact factor: 3.739

9.  RS-WebPredictor: a server for predicting CYP-mediated sites of metabolism on drug-like molecules.

Authors:  Jed Zaretzki; Charles Bergeron; Tao-wei Huang; Patrik Rydberg; S Joshua Swamidass; Curt M Breneman
Journal:  Bioinformatics       Date:  2012-12-14       Impact factor: 6.937

10.  Computational tools and resources for metabolism-related property predictions. 1. Overview of publicly available (free and commercial) databases and software.

Authors:  Megan L Peach; Alexey V Zakharov; Ruifeng Liu; Angelo Pugliese; Gregory Tawa; Anders Wallqvist; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.